Proceedings of the National Academy of Sciences · 1999 · 188 citations · 46 references
MedicineNeuroscienceOncologyGlial BiologyNeoplasiaNeuro-oncologyBrain TumorsGlial Cell BiologyGlial DevelopmentGlial PathologyGlioblastomaNervous TissueGlioblastoma PathologyGlioblastoma Tumor BiologyHistopathology Of Brain TumorsNeoplastic ProgressionOligodendrocyte Precursor Cell BiologyOligodendrocyte Progenitor CellsOligodendroglioma PathologyPlatelet-derived Growth Factor Receptors
The early events in neoplastic transformation can be understood only by comparison of the neoplastic cell with its nontransformed counterpart. The most common central nervous system gliomas traditionally are thought to arise from mature astrocytes and oligodendrocytes. We examined the possibility that gliomas arise from a population of glia that has properties of oligodendrocyte progenitors. These glial cells express the NG2 chondroitin sulfate proteoglycan and the alpha receptor of platelet-derived growth factor in vivo. We identified NG2 and the alpha receptor of platelet-derived growth factor expression in tissue from seven of seven oligodendrogliomas, three of three pilocytic astrocytomas, and one of five glioblastoma multiforme. These data provide evidence that glial tumors arise from glial progenitor cells. Molecules expressed by these progenitor cells should be considered as targets for novel therapeutics.
46
J. Gregory Cairncross, Keisuke Ueki, Magdelena C. Zlatescu et al. · JNCI Journal of the National Cancer Institute · 1998 · 1.6K citations · Full text
A role for platelet-derived growth factor in normal gliogenesis in the central nervous system
William D. Richardson, Nigel P. Pringle, Michael Mosley et al. · Cell · 1988 · 768 citations
Medicine, Neurobiology, Neuroscience +16